MODERATE TO SEVERE CHRONIC PLAQUE PSORIASIS

Clinical trials for MODERATE TO SEVERE CHRONIC PLAQUE PSORIASIS explained in plain language.

Never miss a new study

Get alerted when new MODERATE TO SEVERE CHRONIC PLAQUE PSORIASIS trials appear

Sign up with your email to follow new studies for MODERATE TO SEVERE CHRONIC PLAQUE PSORIASIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Not yet finished but already full! 1 Completed 8

New psoriasis pill enters final testing phase

Disease control Not yet recruiting

This study aims to test the safety and effectiveness of an oral medication called ponesimod for adults with moderate-to-severe plaque psoriasis. It will involve about 300 participants who have a significant amount of their skin affected by the condition. The main goal is to see h…

Matched conditions: MODERATE TO SEVERE CHRONIC PLAQUE PSORIASIS

Phase: PHASE3 • Sponsor: Vanda Pharmaceuticals • Aim: Disease control

Last updated Mar 23, 2026 15:15 UTC

MODERATE TO SEVERE CHRONIC PLAQUE PSORIASIS

Get alerted when new MODERATE TO SEVERE CHRONIC PLAQUE PSORIASIS trials appear

New psoriasis pill enters final testing phase